8oNicotinic acid hydrazide (isoniazid) has antituberculous activity both in vivo and in vitro (Fox, 1951) . In man its principal toxic effect, peripheral neuritis Oestreicher, Dressler & Middlebrook, 1954) , can be prevented by the concurrent administration of vitamin B. (pyridoxine) Biehl & Nimitz, 1954) . It is of interest to discover whether the specific anti-mycobacterial activity of isoniazid is related to its anti-vitamin B6 action.
Inhibition by isoniazid of the growth of a number of bacterial cultures has been demonstrated (Yoneda & Asano, 1953; Lichstein, 1955) as well as inhibition of pyridoxal phosphate-dependent decarboxylases (Davison, 1956; Hoare, 1956) , and of transaminases from Mycobacterium tuberculo8i8 var. avium (Ito & Sugano, 1954) and the Bacille Calmette Gu6rin strain (B.C.G.) of tubercle bacilli (Sakai, 1954) ; reversal of this inhibition was reported by most of these authors. These observations, together with the similarity in the chemical structure of isoniazid and pyridoxal, suggest that isoniazid may compete with vitamin B6 in enzyme systems such as decarboxylases and transaminases which are dependent on this co-factor. This hypothesis is supported by the high antituberculous activity of 2-methylisoniazid, which closely resembles pyridoxal phosphate in structure, in contrast to the markedly lower efficiency of the 2-ethyl analogue, and the inactivity of the higher 2-alkyl compounds as well as of 3-methyl-and 2:5-dimethyl-isoniazid (Isler et al. 1955) .
Evidence for the reversal by vitamin B6 of the antituberculous activity of isoniazid in vitro is conflicting. Pope (1956) found that pyridoxal and pyridoxamine caused reversal of the antituberculous activity, but Oestreicher et al. (1954) obtained reversal only with pyridoxal. Boone & Woodward (1953) and Ungar, Tomich, Parkin & Muggleton (1954) (Ungar et al. 1954; Grunberg & Blencowe, 1955; Wasz-Hockert, McCune & Tompsett, 1956; Brun, Cayre & Viallier, 1954) .
As an alternative to the theory that isoniazid acts as a competitor to vitamin B. Vilter, Biehl, Mueller & Friedman (1954) suggested that inhibition of vitamin B6-dependent enzymes is due to the formation ofa pyridoxal i8onicotinoylhydrazone, by interaction between the aldehyde group of pyridoxal and the hydrazide radical of isoniazid, but they did not isolate this compound. Pyridoxal iaonicotinoylhydrazone was subsequently prepared by Sah (1954) , who reported that it inhibited the growth of tubercle bacilli both in vivo and in vitro. Evidence bearing upon one or other hypothesis should be given by a study of the effect of a group of cyclic hydrazides and related compounds on a pyridoxal-dependent enzyme such as transaminase.
The isoniazid-vitamin B6 antagonism may be due either to a 4-substituted pyridine structure, in which case only isoniazid would be inhibitory, or to Schiff's-base formation, when all hydrazides would be effective. Investigation of the effect of five hydrazides on the alanine-o-oxoglutaric acid transaminase of pig heart showed that this enzyme system was affected equally by all the five substances used, a result in favour of Schiff's-base formation. As only one of these hydrazides has antituberculous properties there appears to be no correlation between the antituberculous and the anti-vitamin B. activities of isoniazid.
MATERIALS AND METHODS
The following hydrazides and related compounds were of analytical purity: isonicotinic acid hydrazide, m.p. 169-5-170-5°, nicotinic acid hydrazide, m.p. 160.5-161-5o, picolinic acid hydrazide, m.p. 100°, benzoic acid hydrazide, m.p. 112-113', i8onicotinamide, m.p. 155-156', nicotinamide, m.p. 128-129', benzamide, m.p. 126-128', i8o-nicotinic Enzyme preparation. The preparation from chilled pig hearts obtained from the slaughterhouse was carried out at 40. Minced heart muscle (300 g.) was homogenized for 2 min. in 900 ml. of0 03m-phosphate buffer, pH 7X2, and the homogenate was centrifuged at 400g for 5-10 min. The supernatant and gelatinous clot of mitochondria were decanted from the residue of cell debris and adjusted to pH 5-4 with 10% (v/v) acetic acid and recentrifuged for 20 min. at 1000 g. The sediment containing the transaminase was dissolved in 150 ml. of 0-067M-phosphate buffer, pH 7-4, and frozen solid in batches of about 25 ml. Immediately before use a batch of the suspension was thawed and homogenized for 2 min., any unused material being discarded.
Determination of transaminase activity. The enzyme suspension was incubated with L-alanine, a-oxoglutaric acid and inhibitors; the amount of glutamic acid produced was estimated by decarboxylation with C(l8tridium welhii by the method of Gale (1945) . In order to produce a consistent degree of inhibition it was necessary (see below) to preincubate the extract with the inhibitor. Enyzme suspension (6 ml.) was pre-incubated for 30 min. at 370 with 6 ml. of 0-067m-phosphate buffer containing the required concentration of inhibitor. At the end of this time 3 ml. each of 0-1x-solutions of L-alanine and a-oxoglutaric acid in phosphate buffer were added. After 10 min. two 3 ml. samples were transferred to centrifuge tubes, which were plunged into boiling water for 5 min. to precipitate protein which was then removed by centrifuging. A portion (1 ml.) of the supernatant was added to 2 ml. of 0-1M-acetate buffer, pH 4.4, in the main compartment of a Warburg flask and the pH was brought back to 4-4 by the addition of 2 or 3 drops of 2N-acetic acid. The bacterial suspension (0-5 ml.) (see below) was placed in the side arm of the flask and, after equilibration at 37°, tipped into the main compartment.
Incubation was continued until no further C00 was evolved.
Preliminary experiments showed (Table 1) that isoniazid did not affect the estimation ofglutamic acid by this method, although the decarboxylase of C. welchii is known to be catalysed by pyridoxal. Incubation of the bacterial suspension with 0-133m-isoniazid before addition of glutamic acid also had no effect on subsequent decarboxylation (Table 1) .
The bacterial suspension was prepared from stock cultures of C. welchii, strain S.R. 12, N.C.T. The rather high concentration of inhibitor required to obtain approximately 50 % inhibition of the transaminase suggested that the effective concentration of hydrazide in the incubation mixture might be reduced by interaction with free pyridoxal present in the crude extract. In that event a reduction in the volume of extract used should result in greater inhibition of the enzyme with the same amount of inhibitor. However, comparison of the inhibitory action of the hydrazides, by using only 2 ml. ofthe enzyme preparation made up to 6 ml. with phosphate buffer, showed no significant change in the percentage inhibition of initial rate of reaction (Table 3) .
Pre-incubation of three of the corresponding amides-i8onicotinamide, nicotinamide and benzamide-with the extract caused no inhibition of the transaminase with a final concentration of 3.3 x 10-2M of these substances, thus emphasizing that the -CONH-NH2 radical was essential for inhibition.
If inhibition of the transaminase by isoniazid involves competition or reaction with the coenzyme pyridoxal phosphate (VI), excess of pyridoxal phosphate might be expected to reverse the inhibition. Unfortunately it was not practicable to demonstrate the reversal of inhibition by isoniazid in the crude enzyme extract used because, at the high concentrations of pyridoxal phosphate required to exceed that of the isoniazid, an unidentified compound was produced which on incubation with C. welehii caused an uptake of gas, masking the production of carbon dioxide from glutamic acid. This effect was not investigated further. Addition of pyridoxal and the pyridoxal phosphate antimetabolites 4-deoxypyridoxine and 4-deoxypyridoxine phosphate all produced inhibition (Table 4) . Addition of isoniazid, together with pyridoxal, produced greater inhibition than pyridoxal alone, while the preformed Schiff's base, pyridoxal iwonicotinoylhydrazone (VII), produced no more inhibition than pyridoxal alone ( It is of interest to consider the possible mechanisms by which isoniazid and the other hydrazides may effect inhibition of the transaminase reaction. The concentration of hydrazide required to produce 50 % inhibition is twice that of a.-oxoglutaric acid, and it might seem on first consideration that the hydrazide was forming a complex with the keto acid and causing inhibition by removal of a substrate. However, the necessity for pre-incubating the enzyme with the hydrazide to obtain inhibition excludes this possibility. A more plausible assumption is that the inhibition is effected in some way through the coenzyme, pyridoxal phosphate. There are then two main ways in which inhibition may be brought about: competition of the hydrazide with pyridoxal phosphate for the enzyme protein, or modification ofthe coenzyme in such a way that it is no longer capable of catalysing transamination. From these results it is unlikely that the hydrazides compete directly with pyridoxal phosphate for the enzyme. If this were so, it would be expected that isoniazid, the only hydrazide tested with a 4-substituted pyridine structure, would alone be inhibitory or at least be more effective than the others. In fact all five were equally potent as inhibitors and more effective in low concentration than the competitive inhibitors, deoxypyridoxine, deoxypyridoxine phosphate and pyridoxal. It seems probable, then, that hydrazides act by modifying the coenzyme in such a way that it is no longer capable of combining with the substrate, e.g. by formation of a Schiff's base as suggested by Davison (1956) to account for inhibition by hydrazide of the cysteine sulphinic acid decarboxylase of the liver. This theory is supported by the necessity of the hydrazide radical for CYMERMAN-CRAIG I957 inhibition of transamination (cf. the inactivity of the corresponding amides) and the reports of inhibition of other pyridoxal phosphate-dependent enzyme systems by hydrazide compounds (Gale, 1946) .
The question then arises whether inhibition is caused by combination of the hydrazide with enzyme-bound pyridoxal phosphate, or by reaction with any free pyridoxal phosphate in solution, to form a Schiff's base which might compete for the enzyme site. The latter is unlikely since pyridoxal i8onicotinoylhydrazone is a less effective inhibitor than isoniazid in the same concentration and at the same pH (Table 4 ). The degree of inhibition of pyridoxal-dependent enzyme systems by hydrazides appears to be related to the strength of the pyridoxal phosphate-enzyme association. The inhibition of bacterial decarboxylases by semicarbazide and hydrazine was reported by Gale (1946) to be much greater in those systems where the co-factor was easily separated from the enzyme than in those in which it was tightly bound. The concentration of hydrazide (3-3 x 10-2M) required to obtain 50 % inhibition in this work, as compared with that (3 x 10-4M) required for 50 % inhibition of the decarboxylase studied by Davison (1956) , is in agreement with the idea that the coenzymeenzyme association in transaminases is particularly strong (Meister, 1955) .
Thus hydrazides may act as inhibitors of transaminases and other pyridoxal phosphate-dependent enzyme systems by combination with the aldehyde group of the pyridoxal phosphate, provoking dissociation of the coenzyme from the enzyme. The variation in effective concentration of hydrazides necessary to produce inhibition of different enzyme systems may be explained by the known variations in strength of the pyridoxal phosphate-enzyme association with different enzyme proteins. SUMMARY 1. The effect of i8onicotinic acid hydrazide, nicotinic acid hydrazide, picolinic acid hydrazide, benzohydrazide and i8onicotinic acid hydrazide methiodide on the alanine-o-oxoglutaric acid transaminase of a pig-heart-muscle extract was studied. All were found to produce approximately 50 % inhibition of glutamic acid production at a concentration of 3-3 x 10-2M.
2. The corresponding amides were without effect on the transaminase.
3. The mechanism of hydrazide inhibition is discussed on the basis of these findings. Previous workers have found that while a di-or mono-hydroxybenzene ring must be present for a sympathomimetic amine to have hyperglycaemic activity, the analogous deoxy compound can still affect the blood pressure. In view of this, the effect on the hyperglycaemic and blood-pressureraising activities of replacing the catechol or benzene ring of sympathomimetic amines by a pyridine ring was studied. Ellis (1951) suggested that in amines with hyperglycaemic activity the side chain is responsible for the attachment to the enzyme complex concemed in adrenaline hyperglycaemia, whereas the catechol nucleus is the active grouping in the production of hyperglyeaemia. Thus, on this hypothesis, it may be possible for a compound having a side chain similar to that of adrenaline to attach itself, and, while exerting no hyperglycaemic effect owing to the lack of the appropriate aromatic structure, block the hyperglycaemic effect of adrenaline administered subsequently. In agreement with this hypothesis Ellis found that ephedrine did, in fact, largely inhibit the adrenaline effect in rats, and this was confirmed for rabbits by Komrad & Loew (1951) .
Some information on how far this ephedrineblocking effect is dependent on an N-methylated hydroxyi8opropylamine side chain attached to a benzene nucleus has now been obtained by using norephedrine and its pyridine analogue and the pyridine analogue of x-aminopropiophenone. Synthetic methods for preparing these two pyridine analogues, namely 3-(2-amino-1-hydroxypropyl)-pyridine (IV) and 3-(2-amino-1-oxopropyl)pyridine (II) respectively, have been developed.
The 3-(2-amino-1-oxopropyl)pyridine was prepared by the action of nicotinic anhydride on abenzamidopropionic acid, according to Dakin & West (1928) , followed by a hydrolysis of the benzamido group. In order to obtain the corresponding hydroxypropyl derivative, which was prepared by catalytic reduction of the ketone, it was necessary first to reduce the benzamido derivative and then hydrolyse, since hydrogenation of the free amine could not be achieved without simultaneous
